Partnership
About Collaboration Research
We aim for collaboration through “win-win” partnerships.
Collaboration begins with a proposal for a new biotherapeutic idea from the collaborating pharmaceutical company. After identifying a target protein for drug discovery, we obtain target-specific cyclic peptides and graft them onto optimal scaffold proteins to create Neobiologics, new biologics desired by the collaborator with expected functions such as agonists and antagonists. The collaborator then evaluates the resulting molecule and works with us to further refine the molecule and create the final target product /and complete the target product.
Based on the agreement reached between the collaborator and us, the finished product will be licensed.
Current Partner Companies
-
Ono Pharmaceutical Co., Ltd.
(Japan)
-
Big U.S. pharmaceutical company
(USA)
Contact Us
We welcome partners who are willing to work with us through collaborative research and development to create unique and innovative biopharmaceuticals that have never existed before.
We believe that by combining our partners' expertise and experience with our LassoGraft Technology®, we can create synergies of more than 1+1=3.
If you have any ideas, suggestions, or questions, please contact us below.